Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-01-04 @ 12:45 AM
Study NCT ID:
NCT02032004
Status:
COMPLETED
Last Update Posted:
2022-01-10
First Post:
2014-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Sponsor:
Mesoblast, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-14
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-08
First Submit QC Date:
None
Study First Post Date:
2014-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-05-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-01-05
Last Update Post Date:
2022-01-10
Last Update Post Date Type:
ACTUAL